During a school outbreak investigation, a 6-year-old boy presents with bilateral parotid swelling, fever (38.5°C), and difficulty swallowing for 2 days. He is fully vaccinated with two doses of MMR. Rapid antigen testing for mumps is positive. What is the most appropriate next step in management?

Explanation

## Clinical Context: Breakthrough Mumps in Vaccinated Child The patient has **confirmed mumps** (positive rapid antigen test) despite **two doses of MMR vaccine**. This is a **breakthrough infection**, which occurs in ~1–2% of fully vaccinated individuals due to primary vaccine failure or waning immunity. **Key Point:** The presence of mumps in a vaccinated child signals a potential outbreak and raises questions about vaccine effectiveness, circulation of new strains, or vaccination coverage gaps in the community. ## Why Outbreak Investigation and Public Health Notification Is the Best Next Step **High-Yield:** The immediate priorities are: 1. **Isolate the child** (respiratory droplet precautions for 5 days after parotid swelling onset) 2. **Notify public health authorities** to trigger outbreak investigation 3. **Investigate outbreak source**: identify other cases, vaccination status of contacts, and vaccine strain vs. wild-type 4. **Assess vaccine effectiveness** in the community and identify vaccination coverage gaps 5. **Implement control measures**: vaccination of susceptible contacts, enhanced surveillance **Clinical Pearl:** Mumps outbreaks in vaccinated populations are increasingly recognized and often involve genotype G strains with reduced vaccine effectiveness. Public health response is essential to prevent further transmission. ## Why Other Options Are Incorrect | Option | Why It Is Wrong | |--------|----------------| | **Booster MMR immediately** | A booster dose will not prevent or treat active mumps infection. Post-exposure prophylaxis with MMR is not effective once symptoms have begun. | | **Lumbar puncture before discharge** | LP is indicated only if clinical signs of meningitis (neck stiffness, altered mental status) are present. Mumps meningitis is usually asymptomatic or mild; routine LP in uncomplicated mumps is not standard. | | **Acyclovir therapy** | Mumps is a paramyxovirus; acyclovir is ineffective. Mumps is self-limiting and managed with supportive care (analgesia, hydration). Antiviral therapy is not indicated. | ## Management Algorithm for Mumps in Vaccinated Individual ```mermaid flowchart TD A[Confirmed mumps in vaccinated child]:::outcome --> B[Isolate + supportive care]:::action B --> C[Notify public health]:::action C --> D{Outbreak suspected?}:::decision D -->|Yes| E[Investigate outbreak source]:::action E --> F[Assess vaccination coverage & strain]:::action F --> G[Implement control measures]:::action D -->|No| H[Routine follow-up]:::action B --> I{Complications?}:::decision I -->|Meningitis signs| J[Lumbar puncture + supportive care]:::action I -->|Orchitis/pancreatitis| K[Symptomatic management]:::action ``` **Mnemonic: MUMPS outbreak response = **M**anagement (isolate), **U**nderstand (investigate), **M**onitor (surveillance), **P**ublic health (notify), **S**train/susceptibility (assess)** **Warning:** Do not confuse mumps meningitis (aseptic, usually benign) with bacterial meningitis. Routine LP is not indicated in uncomplicated mumps.